Articles, App Notes, Case Studies, & White Papers

1. Understanding Post-BREXIT Regulatory Changes Impacting the Clinical Trial Supply Chain

   With many BREXIT provisions now in effect and more to come, supply chains serving clinical trials in the UK and/or EU member states must navigate a complex web of new regulations.

2. Benefits Of Implementing EDC & Medical Coding With RTSM 3/17/2023

   Discover what happened when the Fountayn Platform, including RTSM, was used to support a client’s two-year, Phase III study seeking a cure for multiple sclerosis.

3. Key Considerations For Labeling Your Cell Or Gene Therapy

   As sponsors focus on maintaining the temperature range required for cell and gene therapies, they must also keep in mind the challenges this task presents when properly labeling them for clinical trial distribution.

4. Impact Of Data Concerns In Neurological Clinical Trials: Quality Matters 7/15/2025

   This is Part 1 of a 3-part series demonstrating how robust data analytics can address the real-world implications of data quality issues that affect patients waiting for effective treatments.

5. IMP Labeling: EU CTR Transition Considerations 6/26/2023

   Review current requirements as outlined by the EU Clinical Trial Regulation, supporting guidance, and three key considerations when planning IMP labeling activities for ongoing studies.

6. Global Clinical Supply Solutions For Every Trial

   A reliable clinical supply chain strategy is as essential as a company’s discovery program. Seek a partner who can help guide a comprehensive  strategy and manage day-to-day activities.

7. Outlook 2025: Key Trends & Insights 2/19/2025

   Dive into the key trends and challenges shaping the year ahead, from geopolitical uncertainties to cutting-edge innovation in AI, oncology, and weight-loss therapies.

8. The Crucial Role Of IRT/RTSM In Optimizing Drug Supply Budgets 10/4/2024

   Expand your knowledge of IRT/RTSM systems and their capabilities to tailor supplies to site-specific recruitment, significantly decrease drug waste and costs, ensure efficient IMP management, and more.

9. What Are Decentralized Clinical Trials (DCTs)? 8/23/2022

   Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.

10. Is Your Clinical Supply Strategy Ready For EU CTR? 3/3/2022

    One of the most significant changes in the new EU regulation is Annex VI, which covers changes in the labelling requirements for investigational medical products (IMPs). So, what are the implications of these changes and how will they affect outer immediate packaging?